School Violence Exposure as an Adverse Childhood Experience

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age11-65
SponsorTeachers College, Columbia University

About this trial

This study hypothesize that school safety strategies may contribute to poor mental health and distress among various school populations and proposes the following research questions to be answered through this study:

1. Is there a significant difference in the prevalence of mental health outcomes, perceived school safety, and academic engagement between early adolescent and adolescent students (grades 6 - 12) at schools that have experienced a school shooting and those that have not? 2. Are existing interventions to promote school safety and security associated with poor mental health outcomes among students and school staff? 3. Does the strength of this association between school safety interventions and mental health outcomes differ among students and teachers in those schools who have experienced a school shooting versus among students and teachers in those schools who never experienced a school shooting? And, among our sample of students, are these associations moderated by their ACE history? Participants will be asked to self-report data on their mental health and wellness, and perceived school safety through a survey.

Researchers will compare the surveys from the participants from exposure schools (those who experienced a gun shooting incident) with surveys from the participants from non-exposure schools (those who have not experienced a gun shooting incident)

Eligibility criteria

Qualifiers

The school must consent to participate in the study.

Gun shooting incident

For exposure schools: Must have experienced a gun shooting incident between 1/1/2015-12/31/2022 .

For non-exposure schools: there should not have been a gun shooting incident between 1/1/2011-12/31/2022.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • School shooting incident

Treatment groups

2,500 Participants
are divided into 2 treatment groups

Sponsors and collaborators